Abstract
Familial Mediterranean fever (FMF) is a monogenic autoinflammatory disease characterized by fever and serositis attacks caused by mutations in the MEditerranean FeVer (MEFV) gene encoding the pyrin gene. Gain of the function mutations of the pyrin gene lead to stimulation of pro-inflammatory cytokines. Persistent pro-inflammatory situation in the course of FMF may play a role in the development of some other inflammatory diseases such as Behcet’s disease, psoriasis, and vasculitis. Multiple sclerosis (MS), as a demyelinating disorder, is also more commonly seen in FMF patients compared to the general population. There are scarcely any research reporting that these two diseases coexist in more than one person in the same family. We have discovered cases of FMF and demyelinating disorders in five members of two different families. Besides the two families we are reporting, there are only four other families reported so far. Having combined the data of all these six families, we present a case-based review in this study. We aimed to draw attention of physicians to familial co-occurence of FMF and demyelinating disorders and also to discuss possible mechanisms of the coexistence of these two diseases in light of the literature.
Similar content being viewed by others
References
Sonmez HE, Batu ED, Ozen S (2016) Familial Mediterranean fever: current perspectives. J Inflamm Res 9:13–20
Park YH, Wood G, Kastner DL, Chae JJ (2016) Pyrininflammasome activation and RhoAsignaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol 17:914–921
Korkmaz C, Ozdogan H, Kasapçopur O, Yazici H (2002) Acute phase response in familial Mediterranean fever. Ann Rheum Dis 61:79–81
Tunca M, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Topaloglu R et al (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine 84:1–11
Ozdogan H, Arisoy N, Kasapçapur O et al (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24:323–327
Akar S, Soysal O, Balci A, Solmaz D, Gerdan V, Onen F et al (2013) High prevalence of spondyloarthritis and ankylosing spondylitis among familial Mediterranean fever patients and their first-degree relatives: further evidence for the connection. Arthritis Res Ther 28(15):R21
Balcı-Peynircioğlu B, Kaya-Akça Ü, Arıcı ZS, Avcı E, Akkaya-Ulum ZY, Karadağ Ö et al (2020) Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients. Rheumatology (Oxford) 1(59):1372–1380
Yildiz M, Adrovic A, Tasdemir E, Baba-Zada K, Aydin M, Koker O et al (2020) Evaluation of co-existing diseases in children with familial Mediterranean fever. RheumatolInt 40:57–64
Marek-Yagel D, Berkun Y, Padeh S, Abu A, Reznik-Wolf H, Livneh A et al (2009) Clinical Disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum 60:1862–1866
Akman-Demir G, Gül A, Gürol E, Özdoğan H, Bahar S et al (2006) Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association? J Neurol 253:928–934
Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502–1517
Kümpfel T, Gerdes LA, Wacker T, Blaschek A, Havla J, Krumbholz M et al (2012) Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosis. Mult Scler 18:1229–1238
Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885
McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127
Yildirim ME, Kurtulgan HK, Ozdemir O, Kilicgun H, Aydemir DS, Baser B, Sezgin I (2019) Prevalence of MEFV gene mutations in a large cohort of patients with suspected familial Mediterranean fever in Central Anatolia. Ann Saudi Med 39:382–387
Harirchian MH, Fatehi F, Sarraf P, Honarvar NM, Bitarafan S (2018) Worldwide prevalence of familial multiple sclerosis: a systematic review and meta-analysis. MultSclerRelatDisord 20:43–47
Unal A, Dursun A, Emre U, Tascilar NF, Ankarali H (2010) Evaluation of common mutations in the Mediterranean fever gene in multiple sclerosis patients: is it a susceptibility gene? J NeurolSci 294(1–2):38–42
Shinar Y, Livneh A, Villa Y, Pinhasov A, Zeitoun I, Kogan A, Achiron A (2003) Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients. Genes Immun 4:197–203
Chae JJ, Aksentijevich I, Kastner DL (2009) Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol 146:467Y478
Hauser SL, Doolittle TH, Lincoln R, Brown RH, Dinarello CA (1990) Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology 40:1735–1739
Ugurlu S, Ergezen B, Egeli BH, Selvi O, Ozdogan H (2020) Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience. Rheumatol (Oxf) 9:596. https://doi.org/10.1093/rheumatology/keaa596 (Online ahead of print)
de Jong BA, Huizinga TW, Bollen EL, Uitdehaag BM, Bosma GP, van Buchem MA et al (2002) Production of IL-1beta and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis. J Neuroimmunol 126(1–2):172–179
Cree BAC (2014) Handbook of Clinical Neurology. In: Godin DS (ed) Multiple sclerosis genetics, 3rd edn. Elsevier, US San Francisco, pp 193–209
Mahfouz R, Kreidieh K, Khalek RA, Yazbek S (2017) Familial Mediterranean fever: observations from a pilot gene expression microarray analysis study. Cell MolBiol 63:26–28 (Noisy-le-grand)
Kinikli G, Bektas M, Mısırlıoğlu M, Ates A, Turgay M, Tuncer S et al (2005) Relationship between HLA-DR, HLA-DQ alleles and MEFV gene mutations in familial mediterranean fever (FMF) patients. Turk J Gastroenterol 16:143–146
Ozen S, Demirkaya E, Erer B et al (2016) EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 75:644–651
Siegal S (1964) Familial paroxysmal polyserositis. Analysis of fifty cases. Am J Med 36:893–918
Artemiadis AK, Anagnostouli MC, Alexopoulos EC (2011) Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review. Neuroepidemiology 36:109–120
Mohr DC, Hart SL, Julian L, Cox D, Pelletier D (2004) Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 328(7442):731
Franklin GM, Nelson LM, Heaton RK, Burks JS, Thompson DS (1988) Stress and its relationship to acute exacerbations in multiple sclerosis. J NeurolRehabilit 2:7–11
Author information
Authors and Affiliations
Contributions
Study Concepts and design: CK, DUC, SCK; analysis and interpretation of data: CK, DUC, SCK; drafting of the manuscript: CK, DUC, SCK; critically revision of the manuscript for important intellectual content: CK, DUC, SCK; final approval of the version to be published: CK, DUC, SCK.
Corresponding author
Ethics declarations
Informed consent
Written informed consent was obtained from all patients for publication of this case-based review.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Korkmaz, C., Üsküdar Cansu, D. & Kabay, S.C. Familial coexistence of demyelinating diseases and familial Mediterranean fever. Rheumatol Int 42, 167–173 (2022). https://doi.org/10.1007/s00296-021-04821-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-021-04821-7